$ACRX
DD Notes ~ http://www.ddnotesmaker.com/ACRX
##### recent news/filings ~ source: finance.yahoo.com
Thu, 19 Jun 2014 11:00:00 GMT ~ AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference
- REDWOOD CITY, Calif., June 19, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will present a corporate overview on June 25th. Presentation details are as follows: AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso™, is designed to improve the management of moderate-to-severe acute pain in adult patients in the hospital setting by utilizing a high therapeutic index opioid, through a non-invasive delivery route via a pre-programmed, patient-controlled analgesia device. AcelRx has announced positive results from each of the three completed Phase 3 clinical trials for Zalviso, and has submitted an NDA to the FDA seeking approval for Zalviso in the treatment of moderate-to-severe acute pain in adult patients in the hospital setting. AcelRx plans to initiate a Phase 3 clinical trial for ARX-04, a product candidate for the treatment of moderate-to-severe acute pain in a medically supervised setting, during the second half of 2014. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.
read full: http://finance.yahoo.com/news/acelrx-pharmace...00958.html
*********************************************************
Tue, 17 Jun 2014 13:47:08 GMT ~ AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0%
read full: http://finance.yahoo.com/news/acelrx-pharmace...08466.html
*********************************************************
Mon, 16 Jun 2014 20:35:49 GMT ~ ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of
read full: http://biz.yahoo.com/e/140616/acrx8-k.html
*********************************************************
Tue, 03 Jun 2014 11:00:00 GMT ~ Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management
- REDWOOD CITY, Calif., June 3, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the results of a cost analysis study that showed the use of intravenous patient-controlled analgesia, IV PCA, can typically cost a health system more than $200 in opioid drug and IV PCA equipment costs per patient over a typical 2-day postoperative in-hospital stay. These costs do not include the additional healthcare burden of programming errors and other health risks attributable to IV PCA therapy. The findings are being presented at the 19th Annual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Montreal, Canada. Researchers concluded that although IV PCA is a 40-year old technology, the cost of the treatment in the postoperative setting is not insignificant, suggesting that newer, cost-effective solutions are warranted.
read full: http://finance.yahoo.com/news/results-cost-an...00695.html
*********************************************************
Mon, 02 Jun 2014 20:31:19 GMT ~ ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/140602/acrx8-k.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=ACRX&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=ACRX&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ACRX/company-info
Ticker: $ACRX
OTC Market Place: Not Available
CIK code: not found
Company name: AcelRx Pharmaceuticals, Inc.
Incorporated In:
##### extra dd links
Latest filings: http://www.otcmarkets.com/stock/ACRX/filings
Latest financials: http://www.otcmarkets.com/stock/ACRX/financials
Latest news: http://www.otcmarkets.com/stock/ACRX/news - http://finance.yahoo.com/q/h?s=ACRX+Headlines
Major holdings: http://data.cnbc.com/quotes/ACRX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ACRX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ACRX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ACRX
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=AcelRx+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
Short Sales: http://www.otcmarkets.com/stock/ACRX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ACRX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ACRX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ACRX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ACRX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ACRX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ACRX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ACRX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ACRX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ACRX
Balance Sheet: http://finance.yahoo.com/q/bs?s=ACRX
Cash Flow: http://finance.yahoo.com/q/cf?s=ACRX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ACRX
Bloomberg: http://www.bloomberg.com/quote/ACRX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ACRX
Bussinessweek: http://investing.businessweek.com/research/st...icker=ACRX
Barchart: http://www.barchart.com/quotes/stocks/ACRX
OTC Short Report: http://otcshortreport.com/index.php?index=ACRX
Investopedia: http://www.investopedia.com/markets/stocks/ACRX/?wa=0
http://www.pennystocktweets.com/stocks/profile/ACRX
##### last known share structure ~ source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/ACRX